The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173 · cited 1×
“Genetic modifiers may contribute to the variable expressivity of SCN1A mutations in DS patients and this notion is further suggested by investigations of Scn1a knockout (Scn1a+/−) and Scn1a-R1407X knock-in mouse models of DS (Miller et al., 2013; Ogiwara et al., 2007; Yu et al., 2006).”
Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879 · cited 1×
“Genetic modifiers may contribute to the variable expressivity of SCN1A mutations in DS patients and this notion is further suggested by investigations of Scn1a knockout (Scn1a+/−) and Scn1a-R1407X knock-in mouse models of DS (Miller et al., 2013; Ogiwara et al., 2007; Yu et al., 2006).”
Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission
Han, S., Tai, C., Westenbroek, R. E., Yu, F. H., Cheah, C. S., Potter, G. B., Rubenstein, J. L., Scheuer, T., de la Iglesia, H. O., & Catterall, W. A. (2012) · Nature · doi:10.1038/nature11356 · Cited by 643
Veeramah, K. R., O'Brien, J. E., Meisler, M. H., Cheng, X., Dib-Hajj, S. D., Waxman, S. G., Talwar, D., Girirajan, S., Eichler, E. E., Restifo, L. L., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.01.006 · Cited by 438
Catterall, W. A., Kalume, F., & Oakley, J. C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.187484 · Cited by 428 · cited 1×
“1, is the most commonly discovered cause of monogenic epilepsies (Catterall et al., 2010).”
Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
Brunklaus, A., Ellis, R., Reavey, E., Forbes, G. H., & Zuberi, S. M. (2012) · Brain · doi:10.1093/brain/aws151 · Cited by 366 · cited 1×
“While DS is typically characterized by seizure onset in the first year of life with an ensuing epileptic encephalopathy consisting of cognitive, behavioral, andmotor impairments, the severity of its presentation and progression can be variable (Brunklaus et al., 2012; Zuberi et al., 2011).”
Hippocampal Interneurons in Bipolar Disorder
Konradi, C., Zimmerman, E. I., Yang, C. K., Lohmann, K. M., Gresch, P., Pantazopoulos, H., Berretta, S., & Heckers, S. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.175 · Cited by 115
Cited by
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
Kaplan, J. S., Stella, N., Catterall, W. A., & Westenbroek, R. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711351114 · Cited by 378
Han, Z., Chen, C., Christiansen, A., Ji, S., Lin, Q., Anumonwo, C., Liu, C., Leiser, S. C., Meena, Aznarez, I., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6100 · Cited by 341
“These mice typically have a ~50% rate of premature mortality due to SUDEP (13), although this rate is known to vary between different laboratories and mouse facilities.”
InfluentialFavero, M., Sotuyo, N. P., Lopez, E., Kearney, J. A., & Goldberg, E. M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0193-18.2018 · Cited by 163
Self-citationHedrich, U. B. S., Liautard, C., Kirschenbaum, D., Pofahl, M., Lavigne, J., Liu, Y., Theiss, S., Slotta, J., Escayg, A., Dihné, M., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0721-14.2014 · Cited by 164
“1 in glutamatergic neurons (Ogiwara et al., 2013) and increased Na current density in dissociated pyramidal neurons at older ages (Mistry et al., 2014), our data suggest that interneurons in this model play a crucial role for epileptogenesis, even though there might be additional factors sustaining…”
InfluentialDravet syndrome: a sodium channel interneuronopathy
Catterall, W. A. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.12.007 · Cited by 148
Sun, Y., Paşca, S. P., Portmann, T., Goold, C., Worringer, K. A., Guan, W., Chan, K. C., Gai, H., Vogt, D., Chen, Y.-J. J., et al. (2016) · eLife · doi:10.7554/elife.13073 · Cited by 141
Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
Griffin, A., Hamling, K. R., Hong, S., Anvar, M., Lee, L. P., & Baraban, S. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00573 · Cited by 103
Goff, K. M., & Goldberg, E. M. (2019) · eLife · doi:10.7554/elife.46846 · Cited by 93
Kaneko, K., Currin, C. B., Goff, K. M., Wengert, E. R., Somarowthu, A., Vogels, T. P., & Goldberg, E. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110580 · Cited by 72
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
Metadata
- Authors
- Mistry, A. M., Thompson, C. H., Miller, A. R., Vanoye, C. G., George, & Kearney, J. A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 65
- Pages
- 1-11
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2093473346
- Cited by
- 179
- References
- 8
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.